(Q34498312)

2 August 2017

Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trial (English)

1 reference

2 August 2017

8

T E Starzl

1 reference

2 August 2017

D H Van Thiel

1

1 reference

2 August 2017

H Wright

2

1 reference

2 August 2017

P Carroll

3

1 reference

2 August 2017

K Abu-Elmagd

4

1 reference

2 August 2017

H Rodriguez-Rilo

5

1 reference

2 August 2017

J McMichael

6

1 reference

2 August 2017

W Irish

7

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 May 1995

1 reference

The American Journal of Gastroenterology

2 August 2017

1 reference

2 August 2017

90

1 reference

2 August 2017

5

1 reference

2 August 2017

771-776

1 reference

ACTIVE 'JUVENILE' CIRRHOSIS CONSIDERED AS PART OF A SYSTEMIC DISEASE AND THE EFFECT OF CORTICOSTEROID THERAPY

2 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022515

Late results of the Royal Free Hospital prospective controlled trial of prednisolone therapy in hepatitis B surface antigen negative chronic active hepatitis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022515

Development and prognosis of histologic cirrhosis in corticosteroid-treated hepatitis B surface antigen-negative chronic active hepatitis.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022515

Controlled Prospective Trial of Corticosteroid Therapy in Active Chronic Hepatitis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022515

Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022515

High prevalence of seroimmunologic abnormalities in relatives of patients with active chronic hepatitis or primary biliary cirrhosis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022515

Association of autoimmune active chronic hepatitis with HL-A1,8.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022515

Cyclosporin, a new treatment for autoimmune chronic active hepatitis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022515

Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022515

Influence of aetiology, clinical and histological features on survival in chronic active hepatitis: an analysis of 204 patients.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022515

Immunological aspects of chronic active hepatitis.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022515

Persistent measles virus genome in autoimmune chronic active hepatitis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022515

Histologic features in autoimmune hepatitis.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022515

Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022515

Auto-immune (lupoid) hepatitis: an entity in the spectrum of chronic active liver disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022515

FK 506 used as rescue therapy for human liver allograft recipients

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022515

Retransplantation of liver: a comparison of FK 506- and cyclosporine-treated patients

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022515

Liver transplantation of American veterans under FK 506 immunosuppression: a preliminary report

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022515

A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022515

Long-term follow-up of chronic active hepatitis of moderate severity

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022515

Measles Virus Specific Precipitins in Sera from Patients with Chronic Active Hepatitis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022515

Lymphocyte cytotoxicity to autologous hepatocytes in HBsAg-negative chronic active hepatitis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022515

Lymphocyte cytotoxicity for autologous hepatocytes.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022515

Frequency and significance of antibody to double-stranded DNA in chronic active hepatitis

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022515

FK 506 rescue therapy for resistant rejection episodes in liver transplant recipients

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022515

FK 506 assay past and present--characteristics of FK 506 ELISA

27 October 2018

1 reference

12 December 2020

Use of FK 506 for treatment of chronic rejection after liver transplantation

1 reference

12 December 2020

FK 506 for rescue treatment of acute and chronic rejection in liver allograft recipients

1 reference

12 December 2020

FK 506 rescue therapy in liver transplantation: outcome and complications

1 reference

12 December 2020

Chronic liver disease in young people. Clinical features and course in thirty-three patients

1 reference

12 December 2020

The treatment of active chronic hepatitis with 6-mercaptopurine and azathioprine

1 reference

12 December 2020

Effect of prednisone on the survival of patients with cirrhosis of the liver. A report from the Copenhagen Study Group for Liver Diseases

1 reference

12 December 2020

Chronic active liver disease. The range of histologic lesions, their response to treatment, and evolution

1 reference

12 December 2020

Controlled trial of prednisone and azathioprine in active chronic hepatitis

1 reference

12 December 2020

Failure of customary treatment in chronic active liver disease: causes and management

1 reference

12 December 2020

Corticosteroid-treated chronic active hepatitis in remission: uncertain prognosis of chronic persistent hepatitis

1 reference

12 December 2020

Interaction of HLA and Gm in autoimmune chronic active hepatitis

1 reference

12 December 2020

Chronic active hepatitis: the spectrum of disease

1 reference

12 December 2020

Cellular and humoral immune reactions in chronic active liver disease. I. Lymphocyte subsets in liver biopsies of patients with untreated idiopathic autoimmune hepatitis, chronic active hepatitis B and primary biliary cirrhosis

1 reference

12 December 2020

Autoimmune features as determinants of prognosis in steroid-treated chronic active hepatitis of uncertain etiology

1 reference

12 December 2020

Relapse following treatment withdrawal in patients with autoimmune chronic active hepatitis

1 reference

12 December 2020

Complete resolution of inflammatory activity following corticosteroid treatment of HBsAg-negative chronic active hepatitis

1 reference

12 December 2020

The immunologic diagnosis of chronic active "autoimmune" hepatitis: distinction from systemic lupus erythematosus

1 reference

12 December 2020

HLA A1-B8-DR3 and suppressor cell function in first-degree relatives of patients with autoimmune chronic active hepatitis

1 reference

12 December 2020

Liver cell damage caused by monoclonal antibody against an organ-specific membrane antigen in vivo and in vitro

1 reference

12 December 2020

Immunogenetic studies of autoimmune chronic active hepatitis: HLA, immunoglobulin allotypes and autoantibodies

1 reference

12 December 2020

Autoimmune liver diseases

1 reference

12 December 2020

Autoantibodies to human asialoglycoprotein receptor in autoimmune-type chronic hepatitis

1 reference

12 December 2020

Characterization of liver cytokeratin as a major target antigen of anti-SLA antibodies

1 reference

12 December 2020

Auto-immune features in patients with idiopathic chronic active hepatitis who are seronegative for conventional auto-antibodies

1 reference

12 December 2020

Identifiers

PMCID

3022515

1 reference

2 August 2017

1 reference